The Single‑molecule Sequencer market comprises instruments and consumables that enable real‑time, long‑read DNA/RNA sequencing at the individual molecule level, a capability increasingly critical for precision medicine, complex genome assembly, and advanced drug discovery. Single‑molecule Sequencer market size was estimated at approximately USD 1.2 billion in 2025, and the growth outlook projects a CAGR of 13% from 2026 to 2033, driven by accelerating adoption of long‑read technologies, declining sequencing costs, and expanding clinical genomics applications. Key forces shaping the industry include rapid technology shifts toward higher accuracy and throughput, heightened regulatory focus on clinical validation, and intense competitive dynamics among incumbents such as PacBio and Oxford Nanopore, alongside emerging entrants. The market’s scope spans hardware, reagents, and software solutions across research, clinical diagnostics, and pharmaceutical R&D.